Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT07113717
Starting soon Not applicable

Post Operative Hospital at Home After Colorectal Surgery

NCT07113717 · tracked via the Priya Life Science Denmark tracker
Sponsor
Nordsjaellands Hospital
Phase
Not applicable
Started
2025-12-15
Last updated
2025-08-11

Condition(s) studied

Colo-rectal CancerColo-rectal SurgeryColocolic and Ileocolic AnastomosisColon and/or Rectal Resection With Anastomosis for CancerDiverticular Disease of ColonColon Benign TumorCrohn Disease and Ulcerative ColitisIleostomy ClosureStoma Reversal Procedure

Investigational drug(s) / intervention(s)

virtual Hospital at Home

virtual Hospital at Home: telemedicine set-up, virtual Hospital at Home

Study summary

The goal of this feasibility study is to investigate whether a virtual Hospital at Home is safe and possible for patients undergoing planned minimally invasive colorectal surgery. The study aims to answer the following main questions:

What are the patient- and next-of-kin-related effects, as well as the clinical and organizational effects, of home-based admission? What are the implementation barriers for a full-scale randomized controlled trial? Participants will follow a standardized protocol for their care befor, during and after surgery. However, the care after surgery will be conducted at home using telemedicine.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Planned minimally invasive (laparoscopic or robot-assisted) CRS * No epidural analgesia * No new stoma * Bleeding \< 500 ml * Actual condition assessed to be clinically stable * Meeting the Chung score discharge criteria for ambulatory surgery * Self-reliant or receives sufficient formal care to be care-independent of a primary informal caregiver * Home-based admission will be located within catchment area of the hospital (according to the official address of the individual) * Signed informed written and oral consent Exclusion Criteria: * Patients who cannot comply with self-assessment * Improficiency in Danish * Pregnancy * Conversion to emergency surgery (uncontrolled perforation of bowel, ileus) * Complications during surgery warranting in-hospital admission (observation in intensive care unit or close observation from other specialities, e.g. cardiology)

Primary outcome measure(s)

  • Number of recruited participants — one year
    Recruitment success is defined as 50% of eligible patients

Trial sites (1)

FacilityCityRegionStatus
Department of Surgery Hillerød Denmark

More Nordsjaellands Hospital trials in Denmark

Surviving Pneumonia Recruiting
Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers Recruiting
Impact of Physical Exercise at a Hospital Recruiting
Ultrasound-guided Peripheral Nerve Blocks - a Database Recruiting
Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway Recruiting

Other trials for the same condition

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients Recruiting
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial Active, not recruiting
The AIDPRO-CRC Trial Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07113717 on ClinicalTrials.gov ↗ ← All trials in Denmark